Achieve Life Sciences (ACHV) Goodwill & Intangibles (2016 - 2026)
Achieve Life Sciences (ACHV) posted Goodwill & Intangibles of $1.7 million for Q1 2026, down 3.08% on a QoQ basis from $1.8 million in Q4 2025, and down 11.37% year-over-year from $2.0 million in Q1 2025.
Achieve Life Sciences (ACHV) Goodwill & Intangibles (2016 - 2026) Analysis & Trends
Achieve Life Sciences' Goodwill & Intangibles history runs 11 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 11.37% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 11.37% YoY) and the FY2025 annual result came in at $1.8 million, down 11.11% from the prior year.
- Goodwill & Intangibles was $1.7 million for Q1 2026 at Achieve Life Sciences, down from $1.8 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $2.6 million in Q1 2022 and bottomed at $1.7 million in Q1 2026.
- A 5-year average of $2.2 million and a median of $2.2 million in 2024 frame the typical range for Goodwill & Intangibles.
- Peak annual rise in Goodwill & Intangibles reached 7.84% in 2022, while the deepest fall reached 38.23% in 2022.
- Achieve Life Sciences' Goodwill & Intangibles stood at $2.5 million in 2022, then slipped by 9.01% to $2.2 million in 2023, then dropped by 10.0% to $2.0 million in 2024, then slipped by 11.11% to $1.8 million in 2025, then retreated by 3.08% to $1.7 million in 2026.
- Business Quant data shows ACHV's Goodwill & Intangibles at $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | 2.29 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 2.40 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 2.56 Mn |
| Mar 31, 2022 | 2.62 Mn |
| Dec 31, 2021 | 2.68 Mn |
| Sep 30, 2021 | 2.73 Mn |
| Jun 30, 2021 | 4.15 Mn |